{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:21:36Z","timestamp":1772806896901,"version":"3.50.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>Phosphatidylinositol 3-kinase (PI3K) (EC2.7.1.137) is an enzyme essential for a variety of biological processes, including inflammation and neuroplasticity. There is a close, positive relationship between these biological functions and the action of psychostimulant drugs such as cocaine and methamphetamine (METH). This suggests that the inhibition of PI3K might regulate METH-induced behavior such as hyperlocomotion and stereotyped behavior. To evaluate the effects of PI3K inhibition on METH-induced behavior, mice were treated with wortmannin, a potent PI3K inhibitor, followed by METH. Horizontal locomotion, vertical rearing, and stereotyped behaviors were measured. In addition, additional experiments were conducted to examine the effects of wortmannin on other aspects of behavior. Pretreatment of mice with wortmannin (3 and 10\u2005mg\/kg) significantly inhibited METH (10\u2005mg\/kg)-induced stereotyped behavior in a dose-dependent fashion. Stereotyped biting was most robustly reduced by wortmannin, ameliorating the frequency of total stereotypy. Wortmannin (10 but not 3\u2005mg\/kg) had a significant inhibitory effect on METH (3\u2005mg\/kg)-induced hyperlocomotion. Wortmannin had no effect on other aspects of behavior relevant to emotion or memory. In conclusion, non-glycogen synthase kinase-3\u03b2 (GSK3\u03b2) mediated PI3K signaling pathways appear to contribute to the expression of acute METH effects on locomotion and stereotyped behavior in a manner that is different from PI3K\u2013GSK3\u03b2 mediated signaling.<\/jats:p>","DOI":"10.1097\/fbp.0000000000000871","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:00:25Z","timestamp":1769209225000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Wortmannin, a potent phosphatidylinositol 3-kinase inhibitor, suppresses methamphetamine-induced stereotypy and hyperlocomotion in mice"],"prefix":"10.1097","volume":"37","author":[{"given":"Takahiro","family":"Hamana","sequence":"first","affiliation":[{"name":"Laboratory of Drug Addiction and Experimental Therapeutics, Department of Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobue","family":"Kitanaka","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Addiction and Experimental Therapeutics, Department of Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe"},{"name":"Department of Pharmacology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Scott","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Therapeutics, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotoko","family":"Amagata","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Addiction and Experimental Therapeutics, Department of Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Nakai","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Addiction and Experimental Therapeutics, Department of Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riko","family":"Niki","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Hyogo Medical University, Nishinomiya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Yuze","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Addiction and Experimental Therapeutics, Department of Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kento","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Applied Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Uhl","sequence":"additional","affiliation":[{"name":"Department of Neurology, VA Maryland Healthcare System"},{"name":"Departments of Neurology and Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Kitanaka","sequence":"additional","affiliation":[{"name":"Laboratory of Drug Addiction and Experimental Therapeutics, Department of Pharmacy, School of Pharmacy, Hyogo Medical University, Kobe"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"R1-20260306","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12032-025-02844-9","article-title":"Coumarin derivatives as anticancer agents targeting PI3K-AKT-mTOR pathway: a comprehensive literature review.","volume":"42","author":"Al Hasan","year":"2025","journal-title":"Med Oncol"},{"key":"R2-20260306","doi-asserted-by":"crossref","first-page":"15108","DOI":"10.1007\/s12035-025-05113-y","article-title":"Targeting of the PI3K\/AKT\/GSK3\u03b2 pathway in Parkinson\u2019s disease: a therapeutic blueprint.","volume":"62","author":"AlRuwaili","year":"2025","journal-title":"Mol Neurobiol"},{"key":"R3-20260306","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.physbeh.2009.10.019","article-title":"Effects of PI3K inhibition and low docosahexaenoic acid on cognition and behavior.","volume":"100","author":"Bandaru","year":"2010","journal-title":"Physiol Behav"},{"key":"R4-20260306","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol Ther"},{"key":"R5-20260306","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1096\/fj.07-102442","article-title":"Modulation of voluntary ethanol consumption by beta-arrestin 2.","volume":"22","author":"Bjork","year":"2008","journal-title":"FASEB J"},{"key":"R6-20260306","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00213-013-3166-x","article-title":"Beta-arrestin 2 knockout mice exhibit sensitized dopamine release and increased reward in response to a low dose of alcohol.","volume":"230","author":"Bjork","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"R7-20260306","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1523\/JNEUROSCI.23-32-10265.2003","article-title":"Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice.","volume":"23","author":"Bohn","year":"2003","journal-title":"J Neurosci"},{"key":"R8-20260306","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0955-0674(96)80060-3","article-title":"Phosphoinositide kinases.","volume":"8","author":"Carpenter","year":"1996","journal-title":"Curr Opin Cell Biol"},{"key":"R9-20260306","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bbr.2012.03.027","article-title":"Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse.","volume":"231","author":"Enman","year":"2012","journal-title":"Behav Brain Res"},{"key":"R10-20260306","doi-asserted-by":"crossref","first-page":"118635","DOI":"10.1016\/j.bbamcr.2019.118635","article-title":"Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer.","volume":"1867","author":"Evangelisti","year":"2020","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"R11-20260306","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-025-06949-x","article-title":"Methamphetamine and \u03b1-pyrrolidinopentiophenone (\u03b1-PVP) intravenous self-administration in female and male rats.","author":"Gutierrez","year":"2025","journal-title":"Psychopharmacology (Berl)"},{"key":"R12-20260306","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0929-7855(96)00534-2","article-title":"Inhibitory effect of wortmannin on phosphatidylinositol 3-kinase-mediated cellular events.","volume":"14","author":"Hazeki","year":"1996","journal-title":"J Lipid Mediat Cell Signal"},{"key":"R13-20260306","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1471-4159.2007.05194.x","article-title":"The GSK3 hypothesis of Alzheimer\u2019s disease.","volume":"104","author":"Hooper","year":"2008","journal-title":"J Neurochem"},{"key":"R14-20260306","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nrn2870","article-title":"GSK3 signalling in neural development.","volume":"11","author":"Hur","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"R15-20260306","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF02976641","article-title":"Time courses of pCREB expression after dopaminergic stimulation by apomorphine in mouse brain.","volume":"25","author":"Jang","year":"2002","journal-title":"Arch Pharm Res"},{"key":"R16-20260306","doi-asserted-by":"crossref","first-page":"4209475","DOI":"10.1155\/2019\/4209475","article-title":"GSK-3\u03b2 at the intersection of neuronal plasticity and neurodegeneration.","volume":"2019","author":"Jaworski","year":"2019","journal-title":"Neural Plast"},{"key":"R17-20260306","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cytogfr.2019.03.001","article-title":"Role of the PI3K\/AKT (mTOR and GSK3\u03b2) signalling pathway and photobiomodulation in diabetic wound healing.","volume":"50","author":"Jere","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"R18-20260306","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1740-3391-5-3","article-title":"Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium.","volume":"5","author":"Kaladchibachi","year":"2007","journal-title":"J Circadian Rhythms"},{"key":"R19-20260306","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0361-9230(97)00093-2","article-title":"MK-801 inhibits methamphetamine-induced conditioned place preference and behavioral sensitization to apomorphine in mice.","volume":"44","author":"Kim","year":"1997","journal-title":"Brain Res Bull"},{"key":"R20-20260306","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.neuroscience.2007.05.006","article-title":"Blockade of brain histamine metabolism alters methamphetamine-induced expression pattern of stereotypy in mice via histamine H1 receptors.","volume":"147","author":"Kitanaka","year":"2007","journal-title":"Neuroscience"},{"key":"R21-20260306","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2011.12.043","article-title":"Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice.","volume":"1439","author":"Kitanaka","year":"2012","journal-title":"Brain Res"},{"key":"R22-20260306","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/JEN.S25057","article-title":"Memory impairment and reduced exploratory behavior in mice after administration of systemic morphine.","volume":"9","author":"Kitanaka","year":"2015","journal-title":"J Exp Neurosci"},{"key":"R23-20260306","doi-asserted-by":"crossref","first-page":"173257","DOI":"10.1016\/j.pbb.2021.173257","article-title":"Metoprine, a histamine N-methyltransferase inhibitor, attenuates methamphetamine-induced hyperlocomotion via activation of histaminergic neurotransmission in mice.","volume":"209","author":"Kitanaka","year":"2021","journal-title":"Pharmacol Biochem Behav"},{"key":"R24-20260306","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/npp.2017.247","article-title":"VTA mTOR signaling regulates dopamine dynamics, cocaine-induced synaptic alterations, and reward.","volume":"43","author":"Liu","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"R25-20260306","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0065-230X(02)84007-6","article-title":"Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways.","volume":"84","author":"Manoukian","year":"2002","journal-title":"Adv Cancer Res"},{"key":"R26-20260306","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/diseases7010022","article-title":"Roles of PI3K\/AKT\/GSK3 pathway involved in psychiatric illnesses.","volume":"7","author":"Matsuda","year":"2019","journal-title":"Diseases"},{"key":"R27-20260306","doi-asserted-by":"crossref","first-page":"173020","DOI":"10.1016\/j.pbb.2020.173020","article-title":"The involvement of PI3K\/Akt\/mTOR\/GSK3\u03b2 signaling pathways in the antidepressant-like effect of AZD6765.","volume":"198","author":"Neis","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"key":"R28-20260306","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/msb4100148","article-title":"A homeostatic model of Ikappa B metabolism to control constitutive NF-kappa B activity.","volume":"3","author":"O\u2019Dea","year":"2007","journal-title":"Mol Syst Biol"},{"key":"R29-20260306","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1073\/pnas.1502742112","article-title":"Elucidation of G-protein and beta-arrestin functional selectivity at the dopamine D2 receptor.","volume":"112","author":"Peterson","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-20260306","doi-asserted-by":"crossref","first-page":"189324","DOI":"10.1016\/j.bbcan.2025.189324","article-title":"The duality of GSK-3\u03b2 in urinary bladder cancer: tumor suppressor and promoter roles through multiple signaling pathways.","volume":"1880","author":"Sabeel","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R31-20260306","doi-asserted-by":"crossref","first-page":"eabq8109","DOI":"10.1126\/sciadv.abq8109","article-title":"Functional specialization of different PI3K isoforms for the control of neuronal architecture, synaptic plasticity, and cognition.","volume":"8","author":"S\u00e1nchez-Castillo","year":"2022","journal-title":"Sci Adv"},{"key":"R32-20260306","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3390\/biomedicines13112627","article-title":"The precision-guided use of PI3K pathway inhibitors for the treatment of solid malignancies.","volume":"13","author":"Schmitz","year":"2025","journal-title":"Biomedicines"},{"key":"R33-20260306","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1007\/s12035-014-8805-7","article-title":"Protection of the developing brain with anthocyanins against ethanol-induced oxidative stress and neurodegeneration.","volume":"51","author":"Shah","year":"2015","journal-title":"Mol Neurobiol"},{"key":"R34-20260306","doi-asserted-by":"crossref","first-page":"513","DOI":"10.17219\/acem\/62540","article-title":"Expression of interactive genes associated with apoptosis and their prognostic value for ovarian serous adenocarcinoma.","volume":"25","author":"Shin","year":"2016","journal-title":"Adv Clin Exp Med"},{"key":"R35-20260306","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/jcb.25372","article-title":"Ketamine increases permeability and alters epithelial phenotype of renal distal tubular cells via a GSK-3\u03b2-dependent mechanism.","volume":"117","author":"Shyu","year":"2016","journal-title":"J Cell Biochem"},{"key":"R36-20260306","doi-asserted-by":"crossref","first-page":"116002","DOI":"10.1016\/j.bbr.2025.116002","article-title":"Activation of lateral hypothalamic melanin-concentrating hormone neurons mediates sex-specific patterns of methamphetamine self-administration in rats.","volume":"501","author":"Suarez","year":"2026","journal-title":"Behav Brain Res"},{"key":"R37-20260306","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/adb.12696","article-title":"PI3K activation within ventromedial prefrontal cortex regulates the expression of drug-seeking in two rodent species.","volume":"24","author":"Szumlinski","year":"2019","journal-title":"Addict Biol"},{"key":"R38-20260306","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s11064-005-8390-2","article-title":"Effects of monoamine oxidase inhibitors on methamphetamine-induced stereotypy in mice and rats.","volume":"30","author":"Tatsuta","year":"2005","journal-title":"Neurochem Res"},{"key":"R39-20260306","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1177\/0269881120944159","article-title":"The role of the mTOR pathway in models of drug-induced reward and the behavioural constituents of addiction.","volume":"34","author":"Ucha","year":"2020","journal-title":"J Psychopharmacol"},{"key":"R40-20260306","doi-asserted-by":"crossref","first-page":"11638","DOI":"10.3390\/ijms252111638","article-title":"The importance of phosphoinositide 3-kinase in neuroinflammation.","volume":"25","author":"Wright","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R41-20260306","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/MCB.16.4.1722","article-title":"Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction.","volume":"16","author":"Wymann","year":"1996","journal-title":"Mol Cell Biol"},{"key":"R42-20260306","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1471-4159.2011.07281.x","article-title":"Glycogen synthase kinase 3beta in the nucleus accumbens core is critical for methamphetamine-induced behavioral sensitization.","volume":"118","author":"Xu","year":"2011","journal-title":"J Neurochem"},{"key":"R43-20260306","doi-asserted-by":"crossref","first-page":"25846","DOI":"10.1016\/S0021-9258(19)74466-4","article-title":"Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells.","volume":"268","author":"Yano","year":"1993","journal-title":"J Biol Chem"},{"key":"R44-20260306","first-page":"178","article-title":"[Beta-arrestin2 plays a critical role in reward behaviors induced by cocaine].","volume":"65","author":"Yin","year":"2013","journal-title":"Sheng Li Xue Bao"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:01:27Z","timestamp":1772791287000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000871","relation":{},"ISSN":["0955-8810","1473-5849"],"issn-type":[{"value":"0955-8810","type":"print"},{"value":"1473-5849","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"2025-11-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}